SCHEMBL4916256

SCHEMBL4916256

Cc1cnc(CNC(=O)c2cnccc2C(F)(F)F)cn1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCD O00767 1/20 0.51
ALDH1A1 P00352 3/20 0.47
NPC1 O15118 1/20 0.46
POLB P06746 1/20 0.46
DGAT2 Q96PD7 1/20 0.46
KMT2A Q03164 1/20 0.44
CYP3A4 P08684 2/20 0.43
CYP2C19 P33261 2/20 0.43
KDM4E B2RXH2 1/20 0.43
HPGD P15428 1/20 0.43
ALOX15 P16050 1/20 0.43
HSD17B10 Q99714 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
CYP1A2 P05177 2/20 0.43
WDR5 P61964 1/20 0.42
POLQ O75417 1/20 0.41
NAMPT P43490 2/20 0.41
CYP2C9 P11712 1/20 0.40
TSHR P16473 1/20 0.40
P2RX3 P56373 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4916147 0.85 ALDH1A1 (0.51) ALDH1A1NPC1POLBDGAT2KMT2A
SCHEMBL4916162 0.82 NPC1 (0.50) ALDH1A1NPC1POLBDGAT2KMT2A
SCHEMBL4917603 0.81 ALDH1A1 (0.48) ALDH1A1NPC1POLBDGAT2KMT2A
SCHEMBL4907748 0.81 SORT1 (0.58) ALDH1A1NPC1POLBDGAT2KDM4E
SCHEMBL4919571 0.80 ALDH1A1 (0.51) ALDH1A1NPC1POLBDGAT2KMT2A
SCHEMBL18715596 0.79 SMN1; SMN2 (0.55) ALDH1A1NPC1POLBDGAT2KMT2A
SCHEMBL4914769 0.79 ALDH1A1 (0.55) ALDH1A1NPC1POLBDGAT2CYP2C19
SCHEMBL3752774 0.78 ALDH1A1 (0.56) ALDH1A1NPC1POLBDGAT2NAMPT
SCHEMBL379788 0.78 ALDH1A1 (0.60) ALDH1A1NPC1POLBDGAT2CYP2C19
SCHEMBL1568296 0.77 WDR5 (0.50) ALDH1A1KMT2ACYP3A4WDR5P2RX3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080293674-A1 Azinyl Imidazoazine and Azinyl Carboxamide BAYER CROPSCIENCE AG (DE) 2008-11-27 US disclosed
US-20080293674-A1 Azinyl Imidazoazine and Azinyl Carboxamide BAYER CROPSCIENCE AG (DE) 2008-11-27 US disclosed
US-20080293674-A1 Azinyl Imidazoazine and Azinyl Carboxamide BAYER CROPSCIENCE AG (DE) 2008-11-27 US disclosed
CN-1980926-A Azinyl imidazoazine and azinyl carboxamide BAYER CROPSCIENCE AG (DE) 2007-06-13 CN disclosed
EP-1751152-A2 AZINYL IMIDAZOAZINE AND AZINYL CARBOXAMIDE Bayer CropScience Aktiengesellschaft (DE) 2007-02-14 EP disclosed
WO-2005113553-A2 AZINYL IMIDAZOAZINE AND AZINYL CARBOXAMIDE BAYER CROPSCIENCE AG (DE) 2005-12-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293674-A1 Azinyl Imidazoazine and Azinyl Carboxamide AZI2, NISCH, ZYX SCD 4864/4885ALDH1A1 1233/4885NPC1 2845/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.